H19 and urothelial carcinoma: BC‐819 (inodiftagene vixteplasmid), or DTA‐H19, is a plasmid DNA with Diphtheria Toxin A regulated by the H19 promoter combined with polyethylenimine (PEI) that selectively targets urothelial carcinoma cells through H19 promoter overexpression.